| Sign In to gain access to subscriptions and/or personal tools. |
Tyrosine Kinase-Mediated Activation of Cytosolic Calcium Oscillations and Phastic Myometrical Contractions
Section of Maternal-Fetal Medicine, Department of Obstetrics and Gynecology, University of Chicago, Chicago, Illinois
Section of Maternal-Fetal Medicine, Department of Obstetrics and Gynecology, University of Chicago, Chicago, Illinois; Department of Obstetrics and Gynecology, University of Chicago, 5841 S. Maryland Avenue, Chicago, IL 60637; mphillip{at}babies.bsd.uchicago.edu
These studies sought to test the hypothesis that tyrosine kinase-stimulated phasic myometrical contractions are mediated by activation of the phosphatidylinositol (PI)-signaling pathway and the generation of cytosolic calcium oscillations. For these studies, uterine tissue was obtained from adult female Sprague-Dawley white rats during the proestrus/estrus phase of the cycle. In vivo contraction studies were performed using pervanadate (a tyrosine phosphatase inhibitor) with and without inhibitors of the PI-signaling pathway, including 2-nitro-4-carboxyphenyl-N,N-diphenylcarbamate (a phospholipase C inhibitor), thimerosal (an inositol-trisphosphate receptor/channel inhibitor), and Ruthenium red (a ryanodine receptor inhibitor), and with oxytocin or prostaglandin F2
Key Words: Cytosolic calcium oscillations myometrium pervanadate phasic myometrical contractions phosphatidylinositol signaling pathway tyrosine kinase
Journal of the Society for Gynecologic Investigation, Vol. 6, No. 5,
240-244 (1999) |
|
||

(two classic uterotonic agonists). Cytosolic calcium studies were performed using Fura-2-loaded myometrial strips. During these studies, pervanadate was observed to produce cytosolid calcium oscillations and phasic contractions in myometrical tissue comparable to those produced in response to oxytocin and prostaglandin F2